منابع مشابه
Is metformin cardioprotective?
The study by Johnson et al. (1) in the December 2002 issue of Diabetes Care makes conclusions that in part seem to support the controversial finding of the U.K. Prospective Diabetes Study (UKPDS) that metformin usage as monotherapy was associated with a lower death rate compared with sulfonylureas or insulin (2,3). Such a claim has huge importance to practitioners and patients. Diabetes inciden...
متن کاملCardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
OBJECTIVE The clinical use of doxorubicin, which is a strong antineoplastic agent, is limited due to its cardiotoxic side effects. Metformin is a drug with antihyperglycemic effects, and it has been shown to have a cardioprotective effect on left ventricular function in experimental animal models of myocardial ischemia. The present study investigated the cardioprotective effect of metformin in ...
متن کاملIs “The Japan Diet” Cardioprotective?
Lifestyle modifications such as diet change and exercise therapy are recommended as first-line therapy for risk factors for atherosclerotic cardiovascular diseases (ASCVD). Ancel Keys et al., in their landmark epidemiological study, the Seven Countries Study, which started in 1958 1) , reported that a high serum cholesterol level is a risk factor for coronary artery diseases (CAD) and that a hi...
متن کاملGerosuppressant Metformin: less is more
Further expanding the major findings of the landmark study by Harrison and colleagues showing that late-life pharmacological inhibition of the enzyme mammalian Target Of Rapamycin (mTOR) –a conserved integrator of nutrient and growth factor signaling-is sufficient to significantly extend lifespan in mice on rapamycin feeding [1], Selman and colleagues have recently revealed that loss of the rib...
متن کاملIs amlodipine more cardioprotective than other antihypertensive drug classes?
Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. pISSN 1226-3303 eISSN 2005-664...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetes Care
سال: 2003
ISSN: 0149-5992,1935-5548
DOI: 10.2337/diacare.26.1.243